Join Growin Stock Community!

生展8279.TW Overview

TW StockBiotech. & Medical
(No presentation for 8279)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

生展（8279）Overall Performance

生展（8279）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

生展（8279） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

生展（8279）Key Information

生展（8279）Profile

Syngen Biotech Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally. The company offers dietary supplements; supplement contract manufacturing services in the form of sachets, liquids, tablets, cup package capsules, jellies, aluminum and glass bottles, and gummies; science-based and bio active pharmaceutical ingredients under the Oraltics, IMMUPHYLA, V3, ST4SanTex, GUARDSPO, benefiGANO, EXPUNERGY, and BIOJOVIAL brands; and private labelling services. It also provides organic food OEM/ODM, explosion proof extraction, brand agency, and wholesale distribution services. The company serves the sport nutrition, beauty enhancement, baby and mother care, weight management, and digestion and detox industries. It exports to approximately 20 countries. Syngen Biotech Co.,Ltd. was founded in 1988 and is based in Tainan City, Taiwan.

生展（8279）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
8.91
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
33.87%
Net Margin
12.71%
Revenue Growth (YoY)
6.10%
Profit Growth (YoY)
-0.05%
3-Year Revenue Growth
-2.33%
3-Year Profit Growth
-9.47%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-
PE Ratio (TTM)
-
Forward PE
8.91
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
33.87%
Net Margin
12.71%
Revenue Growth (YoY)
6.10%
Profit Growth (YoY)
-0.05%
3-Year Revenue Growth
-2.33%
3-Year Profit Growth
-9.47%
default symbol

8279

生展

115.50D

-3.03%

(-0.03)

  • When is 8279's latest earnings report released?

    The most recent financial report for 生展 (8279) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 8279's short-term business performance and financial health. For the latest updates on 8279's earnings releases, visit this page regularly.

  • Where does 8279 fall in the P/E River chart?

    According to historical valuation range analysis, 生展 (8279)'s current price-to-earnings (P/E) ratio is 9.39, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 8279?

    According to the latest financial report, 生展 (8279) reported an Operating Profit of 39.74M with an Operating Margin of 8.28% this period, representing a decline of 42.89% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 8279's revenue growth?

    In the latest financial report, 生展 (8279) announced revenue of 479.78M, with a Year-Over-Year growth rate of 1.05%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 8279 have?

    At the end of the period, 生展 (8279) held Total Cash and Cash Equivalents of 275.47M, accounting for 0.09 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 8279 go with three margins increasing?

    In the latest report, 生展 (8279) achieved the “three margins increasing” benchmark, with a gross margin of 28.07%%, operating margin of 8.28%%, and net margin of 7.9%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 8279's profit trajectory and future growth potential.

  • Is 8279's EPS continuing to grow?

    According to the past four quarterly reports, 生展 (8279)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 1.4. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 8279?

    生展 (8279)'s Free Cash Flow (FCF) for the period is 22.84M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 26.36% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.